Drugs / CDC-9 Inactivated Rotavirus Vaccine (IRV)
CDC-9 Inactivated Rotavirus Vaccine (IRV)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06962904 | Jul 2025 → Oct 2026 expected | Rotavirus infection | Centers for Disease Control and Prevention | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDC-9 Inactivated Rotavirus Vaccine (IRV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06962904 ↗ |
| Known as | CDC-9 IRV | “CDC-9 IRV dissolving MNP for intradermal administration” NCT06962904 ↗ |
| Known as | IRV | “CDC-9 inactivated rotavirus vaccine (IRV) microneedle patch (MNP)” NCT06962904 ↗ |
| Modality | Vaccine | “inactivated rotavirus vaccine (IRV)” NCT06962904 ↗ |